π
|
Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.
12 auth.
A. Auricchio,
C. Stellbrink,
S. Sack,
M. Block,
J. Vogt,
P. Bakker,
...
C. Huth,
F. SchΓΆndube,
U. Wolfhard,
D. BΓΆcker,
O. Krahnefeld,
H. Kirkels
|
10 |
2002 |
10 π
|
π
|
Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group.
13 auth.
A. Auricchio,
C. Stellbrink,
M. Block,
S. Sack,
J. Vogt,
P. Bakker,
H. Klein,
Andrew P. Kramer,
Jiang Ding,
R. Salo,
...
B. Tockman,
T. Pochet,
J. Spinelli
|
9 |
1999 |
9 π
|
π
|
Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances.
10 auth.
C. Stellbrink,
O. Breithardt,
A. Franke,
S. Sack,
P. Bakker,
A. Auricchio,
...
T. Pochet,
R. Salo,
Andrew P. Kramer,
J. Spinelli
|
8 |
2001 |
8 π
|
π
|
The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study.
8 auth.
A. Auricchio,
C. Stellbrink,
S. Sack,
M. Block,
J. Vogt,
P. Bakker,
...
P. Mortensen,
H. Klein
|
8 |
1999 |
8 π
|
π
|
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
9 auth.
E. Wever,
R. Hauer,
F. V. VAN CAPELLE,
J. Tijssen,
H. Crijns,
A. Algra,
...
A. Wiesfeld,
P. Bakker,
E. O. Robles de Medina
|
7 |
1995 |
7 π
|
π¦
|
Biventricular Pacing in End-Stage Heart Failure Improves Functional Capacity and Left Ventricular Function
8 auth.
P. Bakker,
H. Meijburg,
J. D. de Vries,
M. Mower,
Andra C. Thomas,
M. Hull,
...
E. O. Robles de Medina,
J. BredΓ©e
|
7 |
2000 |
7 π¦
|
π
|
Acute effects of cardiac resynchronization therapy on left ventricular Doppler indices in patients with congestive heart failure.
10 auth.
O. Breithardt,
C. Stellbrink,
A. Franke,
O. Balta,
B. Diem,
P. Bakker,
...
S. Sack,
A. Auricchio,
T. Pochet,
R. Salo
|
7 |
2002 |
7 π
|
π
|
Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.
10 auth.
E. Wever,
R. Hauer,
G. Schrijvers,
F. V. VAN CAPELLE,
J. Tijssen,
H. Crijns,
...
A. Algra,
H. Ramanna,
P. Bakker,
E. O. Robles de Medina
|
6 |
1996 |
6 π
|
π¬
|
Changes in Cerebral Oxygen Uptake and Cerebral Electrical Activity During Defibrillation Threshold Testing
J. D. de Vries,
P. Bakker,
G. Visser,
J. Diephuis,
A. V. van Huffelen
|
6 |
1998 |
6 π¬
|
π¬
|
Abnormal Automaticity as Mechanism of Atrial Tachycardia in the Human HeartβElectrophysiologic and Histologic Correlation:
JACQUES M.T. Barker,
R. Hauer,
P. Bakker,
A. Becker,
M. Janse,
E. O. Medina
|
5 |
1994 |
5 π¬
|
π¬
|
The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation.
E. Vriens,
P. Bakker,
J. W. Vries,
G. Wieneke,
A. V. van Huffelen
|
5 |
1996 |
5 π¬
|